article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

Seminars in Arthritis and Rheumatism. Related Videos Related Content Advertisement June 10th 2025 Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems Aislinn Antrim, Managing Editor June 3rd 2025 S2. Meloxicam: Selective COX-2 inhibition in clinical practice. December 21, 2004. Subscribe Now!

article thumbnail

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Pharmacy Times

Christina Madison and Hillary Blackburn Pharmacy Focus Episode 44: Psychosocial Outcomes in Patients with IBD Pharmacy Focus Episode 45: Pharmacy in Pop Culture with Let's Pharmonize Pharmacy Focus Episode 46: Pharmacy in Pop Culture with Let's Pharmonize- Part 2 Pharmacy Focus Episode 47: How to Counsel Patients on Allergic Rhinitis Pharmacy (..)

article thumbnail

A New Pharmaceutical Product | Case Study

PharmaState Academy

Distribution Strategy: Establishing partnerships with leading hospital chains, clinics, and diagnostic centers for inpatient and outpatient sales. Hosting advisory board meetings, roundtable discussions, and educational seminars to solicit feedback and insights from healthcare professionals.